Intervention
Brachytherapy
ClinicalTrials.gov intervention label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 24 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
24 shownNeoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerNCT07182279 · 2025-08-01
RECRUITINGHigh Dose Rate (HDR) Brachytherapy Salvage After ProstatectomyNCT06982469 · 2020-05-05
RECRUITINGRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerNCT06129851 · 2023-11-20
NOT_YET_RECRUITINGProstate Reirradiation Toxicity Outcomes Feasibility StudyNCT05614700 · 2022-11-15
NOT_YET_RECRUITINGA Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerNCT05100472 · 2021-10-19
ACTIVE_NOT_RECRUITINGRectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate CancerNCT05224869 · 2021-08-31
TERMINATEDStudy of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)NCT04634877 · 2021-01-10
ACTIVE_NOT_RECRUITINGStudy of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)NCT04221945 · 2020-05-12
COMPLETEDCombination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyNCT03543189 · 2018-10-03
COMPLETEDDeformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate BrachytherapyNCT02790216 · 2016-06-01
UNKNOWNSalvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation TherapyNCT03238066 · 2015-04-01
UNKNOWNIntraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and UltrasoundNCT02225925 · 2014-10-01
COMPLETEDFeasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate CancerNCT01982786 · 2014-04-22
COMPLETEDModulated Electro-Hyperthermia Plus Chemo-radiation for Locally Advanced Cervical Cancer Patients in South AfricaNCT03332069 · 2014-01-09
UNKNOWNFocal Therapy for Prostate CancerNCT01802307 · 2013-02-01
WITHDRAWNImmune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or BrachytherapyNCT01777802 · 2013-01-02
COMPLETEDHigh-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNCT01655836 · 2012-10-04
ACTIVE_NOT_RECRUITINGStudy to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate CancerNCT01374087 · 2011-11-01
TERMINATEDAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerNCT01368588 · 2011-07-01
ACTIVE_NOT_RECRUITINGImplant Radiation Therapy or Surgery in Treating Patients With Prostate CancerNCT01098331 · 2008-06-01
TERMINATEDBrachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to LiverNCT00891800 · 2007-07-01
TERMINATEDClinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate CancerNCT00770822 · 2007-04-01
UNKNOWNBrachytherapy for Prostatic Carcinoma PatientsNCT00525720 · 2006-08-01
ACTIVE_NOT_RECRUITINGMagnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerNCT00039624 · 2002-06-03
COMPLETEDCommon conditions
Prostate Cancer18Adenocarcinoma of the Prostate2Brachytherapy1Breast Cancer1Breast Cancer Metastatic to the Liver1Cervical Cancer1Endometrial Neoplasms1Local Recurrence of Malignant Tumor of Prostate1Lung Cancer1Melanoma1Prostate Cancer (Adenocarcinoma)1Prostate Disease1Prostatectomy1Prostatic Neoplasms1Radiotherapy Side Effect1Radiotherapy; Complications1Recurrent Prostate Cancer1Stage IIA Prostate Cancer1Stage IIB Prostate Cancer1Stage IIC Prostate Cancer AJCC v81Stage III Prostate Cancer AJCC v81Stage IV Prostate Cancer AJCC v81Uterine Cervical Neoplasms1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
Leading sponsors
Merck Sharp & Dohme LLC
2
Canadian Cancer Trials Group
1
Clinica Universidad de Navarra, Universidad de Navarra
1
H. Lee Moffitt Cancer Center and Research Institute
1
Icahn School of Medicine at Mount Sinai
1
Ipsen
1
Jeffrey Kotzen
1
M.D. Anderson Cancer Center
1
Mayo Clinic
1
Memorial Sloan Kettering Cancer Center
1
National Cancer Institute (NCI)
1
Radiation Therapy Oncology Group
1
Sheba Medical Center
1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
1
Trial status mix
COMPLETED6
ACTIVE_NOT_RECRUITING5
TERMINATED4
UNKNOWN4
NOT_YET_RECRUITING2
RECRUITING2
WITHDRAWN1
Phase mix
PHASE29
NA7
PHASE34
PHASE13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.